Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiming Luo

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Cancer Research|February 18, 2026
CCL5hi-CD4+ T cells Regulate Macrophage Polarization and Promote Immunotherapy Response in Bladder CancerWeiming Luo, Yapeng Wang, Haitao Wang, et al.
Journal of Neurochemistry|December 24, 2009
Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemiaTae Gen Son, Simonetta Camandola, Thiruma V Arumugam, et al.
Journal of Neuroinflammation|May 31, 2012
Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's diseaseDavid Tweedie, Ryan A Ferguson, Kelly Fishman, et al.
The Journal of Pathology|July 18, 2024
Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1-SNAI1 axisZe Wang, Peng Tang, Haiyang Xiao, et al.
Geroscience|March 17, 2025
3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the ratKai-Yun Chen, Shih-Chang Hsueh, Pathik Parekh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 2, 2022
Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesisDaniela Lecca, Yoo Jin Jung, Michael T Scerba, et al.
Journal of Biomedical Science|June 16, 2025
Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegenerationShih Chang Hsueh, Pathik Parekh, Buyandelger Batsaikhan, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Cancer Research|February 18, 2026
CCL5hi-CD4+ T cells Regulate Macrophage Polarization and Promote Immunotherapy Response in Bladder CancerWeiming Luo, Yapeng Wang, Haitao Wang, et al.
Journal of Neurochemistry|December 24, 2009
Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemiaTae Gen Son, Simonetta Camandola, Thiruma V Arumugam, et al.
Journal of Neuroinflammation|May 31, 2012
Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's diseaseDavid Tweedie, Ryan A Ferguson, Kelly Fishman, et al.
The Journal of Pathology|July 18, 2024
Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1-SNAI1 axisZe Wang, Peng Tang, Haiyang Xiao, et al.
Geroscience|March 17, 2025
3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the ratKai-Yun Chen, Shih-Chang Hsueh, Pathik Parekh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 2, 2022
Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesisDaniela Lecca, Yoo Jin Jung, Michael T Scerba, et al.
Journal of Biomedical Science|June 16, 2025
Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegenerationShih Chang Hsueh, Pathik Parekh, Buyandelger Batsaikhan, et al.
Pageof 6